Canonical Cd95l was expressed in none of the glioma cell lines in vitro, as assessed by RT-qPCR using a primer pair targeting a region of the first Cd95l exon uniquely present in transcript variant 1 (Fig. 1c, left). This evidence concerns the gene FASLG and central nervous system cancer.